Barriers and facilitators for implementing a pharmacogenetic passport: lessons learned from reusing sequencing data
When considering the implementation of a pharmacogenetic passport, strategies can be developed to diminish barriers and strengthen facilitators. It is important to focus on data infrastructure, (visibility of) guidelines, clear division of tasks, and pharmacogenetic education.
Authors
- Lidewij Henneman (ORCID: https://orcid.org/0000-0003-3531-0597)
- Daoud Sie (ORCID: https://orcid.org/0000-0001-6762-2582)
- Tessel Rigter (ORCID: https://orcid.org/0000-0002-6038-6289)
- Martina C. Cornel (ORCID: https://orcid.org/0000-0002-5397-5544)
- Pierre M. Bet (ORCID: https://orcid.org/0000-0001-6735-7379)
- Carla van El (ORCID: https://orcid.org/0000-0003-2201-2320)
- A. Roelofsen (ORCID: https://orcid.org/0009-0007-3984-0102)
- Loes Lindiwe Kreeftenberg (ORCID: https://orcid.org/0000-0003-1261-2787)
Institutions
- Amsterdam University Medical Centers (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Pharmacogenomics
- Published
- 2025-04-13
- DOI
- https://doi.org/10.1080/14622416.2025.2504862
- Citations
- 1
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.56
Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek